Pathogenetic mechanisms of alopecia areata

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article presents data on alopecia areata (AA), a chronic inflammatory disease caused by hair loss with primarily genetic component. The frequency of occurrence of AA reaches 1–2% of the total population as a whole. AA can develop at any age. At the same time, in most patients, the first episode occurs before the age of 40 years, with a maximum onset between the second and fourth decades. In some patients, hair loss can develop into severe and chronic hair loss and cause severe psychosocial stress. Despite extensive research in the field of AA, the current understanding of pathogenesis is still incomplete. Genetic epidemiological studies are known to be effective in studying associations between gene variations with common diseases. The importance of genetic factors in AA is evident due to the high frequency of a positive family history. The article presents variants of genetic predisposition to AA, considers related and unrelated genes of the human leukocyte antigen in AA.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Alina Kazhzhanova

Kazan State Medical Academy – Branch Campus of RMACPE

Хат алмасуға жауапты Автор.
Email: skinderma@rambler.ru
ORCID iD: 0000-0002-9803-5732
SPIN-код: 5514-7647

External Doctorate Student at the Department of Dermatovenereology and Cosmetology

Ресей, Kazan

L. Yusupovа

Kazan State Medical Academy – Branch Campus of RMACPE

Email: skinderma@rambler.ru
ORCID iD: 0000-0001-8937-2158
SPIN-код: 5743-6872
Ресей, Kazan

Әдебиет тізімі

  1. Гнездная алопеция. Клинические рекомендации. 2020. 61 с. [Nest alopecia. Clinical guidelines. 2020. 61 р. (In Russ.)].
  2. Догов А.М., Мурашкин Н.Н., Амбарчян Э.Т. и др. Психический статус и качество жизни пациентов детского возраста с гнездной алопецией: одномоментное (опросное) исследование. Фарматека. 2022;14:55–61. [Dogov A.M., Murashkin N.N., Ambarchyan E.T., et al. Mental status and quality of life in pediatric patients with alopecia areata: a cross-sectional (questionnaire) study. Farmateka. 2022;14:55–61 (In Russ.)]. doi: 10.18565/pharmateca.2022.14.55-61.
  3. Шатохина Е.А., Круглова Л.С., Полонская А.С. Диффузная алопеция: триггерные факторы и лечение. Фарматека. 2019;8:18–21. [Shatokhina E.A., Kruglova L.S., Polonskaya A.S. Diffuse alopecia: trigger factors and treatment. Farmateka. 2019;8:18–21. (In Russ.)]. doi: 10.18565/pharmateca.2019.8.18-21.
  4. Юсупова Л.А. Современное состояние проблемы эксфолиативного дерматита. Лечащий врач. 2019; 11:6–8. [Yusupova L.A. The current state of the problem of exfoliative dermatitis. Lechashchii vrach. 2019;11:6–8. (In Russ.)].
  5. Joss-Wichman E., Broniarczyk-Dyła G. Współczesne poglądy na etiopatogenezȩ łysienia plackowatego. Post Derm Alergol. 2005; 22:189–98.
  6. Юсупова Л.А. Современный взгляд на проблему старения кожи. Лечащий врач. 2017;6:75. [Yusupova L.A. Modern view on the problem of skin aging. Lechashchii vrach. 2017;6:75. (In Russ.)].
  7. Кажжанова А.М. Изучение атиоксидантных ферментов у пациентов гнездной алопецией. Сборник материалов III Всероссийского Конгресса клинической медицины с международным участием им. С.С. Зимницкого. 2022. С. 45–8. [Kazhzhanova A.M. Study of antioxidant enzymes in patients with nest alopecia. Collection of materials of the III All-Russian Congress of Clinical Medicine with international participation. S.S. Zimnitsky. 2022. Р. 45–8 (In Russ.)].
  8. Юсупова Л.А., Мингазетдинова Н.И. Сов-ременное состояние проблемы сухой кожи. Лечащий врач. 2014;5:41. [Yusupova L.A., Mingazetdinova N.I. The current state of the problem of dry skin. Lechashchii vrach. 2014;5:41. (In Russ.)].
  9. Hartl M. Autoimmune skin diseases. Pathogenesis, diagnosis, treatment. Springer-Verlag/Wien. 2011. 593 р.
  10. Sharma V.K., Dawn G., Kumar B. Profile of focal alopecia in Northern India. Int J Dermatol. 1996;35:22–7. doi: 10.1111/j.1365-4362.1996.tb01610.x.
  11. Safavi H., Muller S.A., Suman V.J., et al. 3rd incidence of focal alopecia in Olmsted County, Minnesota. Mayonnaise Clin. Proc. 1995; 70:628–33.
  12. Betterle K., Greggio N.A., Volpato M. Clinical review 93. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83:1049–55. doi: 10.1210/jcem.83.4.4682.
  13. McElwee K.J., Boggess D., Olivri T., et al. Comparison of focal alopecia in human mammals and non-human species. Pathobiol. 1998; 66:90–107.
  14. Kurtev A., Iliev E. Thyroid autoimmunity in children and adolescents with focal alopecia. Int. J Derm. 2005;l44:457–61. doi: 10.1111/j.1365-4632.2005.01971.x.
  15. Ito T., Tokura Yu. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in focal alopecia. Exp Dermatol. 2014;23:787–91. doi: 10.1111/exd.12489.
  16. Betz R. K., Petukhova L., Ripke S., et al. A genome-wide meta-analysis of focal alopecia eliminates HLA associations and identifies two new loci of susceptibility. Natural Commune. 2015;66:1–8.
  17. Moravvey H., Tabatabai-Panah P.S., Abgun R., et al. Association of genetic variants PTPN22, CTLA4, IL2RA, as well as HLA frequencies with a predisposition to focal alopecia. Immunol Invest. 2018;47:666–79. doi: 10.1080/08820139.2018.1480032.
  18. Petukhova L., Duvich M., Gordinsky M., et al. A genome-wide study of the association in focal alopecia suggests the presence of both innate and adaptive immunity. Nature. 2010;466:113–17. doi: 10.1038/nature09114.
  19. Alhamdi M.A., AL-Aidan L.N., Al jamal H.A., et al. Genetic association of single nucleotide polymorphisms IL 2RA, IL17RA, IL23R and IL 31RA with focal alopecia. Saudi J Biol Sci. 2022;29(11):103460. doi: 10.1016/j.sjbs.2022.103460.
  20. AL-Aidan L.N., Al hamdi M.A., Al Momani R.O., et al. Genetic predisposition to focal alopecia in Jordanians: a case-control study. Ecol Collect. 2022;8(4):e09184. doi: 10.1016/j.heliyon.2022.e09184.
  21. Mahir Sh.A., Ismail N.A., Tora E.A., et al. Serum expression of microRNA-34a associated with hair follicles and rs2666433A/G variant in patients with alopecia: cross-sectional analysis. Biomolecules. 2022;12(5):602. doi: 10.3390/biom12050602.
  22. Broker E.B., Ehternacht-Happle K., Hamm H., Happle R. Abnormal expression of major histocompatibility antigens of class I and class II and in focal alopecia: modulation by local immunotherapy. J Invest Dermatol. 1987;88:564–68. doi: 10.1111/1523-1747.ep12470166.
  23. Kolomb B.V., Lu C.D., In Price X. The genetic basis of focal alopecia: associations of the HLA system with focal focal alopecia in comparison with total and universal alopecia. J Invest Dermatol. Symp Proc. 1999;4:216–19.
  24. Galbraith G.M., Palesh U., Gore E.A., J. Pandey.P. Contribution of interleukin 1beta and KM loci to focal alopecia. Hum Inherited. 1999;49:85–9. doi: 10.1159/000022850.
  25. Betz R.S., Petukhova L., Repke S., et al. A genome-wide meta-analysis of focal alopecia eliminates associations with HLA and identifies two new susceptibility loci. Nat Communicat. 2015;6:5966. doi: 10.1038/ncomms6966.
  26. Rajabi F., Abdollahimaid F., Jabalameli N. Immunogenetics of focal alopecia. Achievements in experimental medicine and biology. Immunogenet Dermatol Dis. 2022;1367:19–59.
  27. Brown R.S. Autoimmune thyroiditis in childhood. J Clin Res Pediatr Endocrinol. 2013;5(1):45–9. doi: 10.4274/jcrpe.855.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2023

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>